Maverick Capital’s Belite Bio BLTE Stock Holding History
Bought
Maintained
Sold
Other funds holding BLTE
DGM
Maverick Capital's BLTE Position: Q3 2026 in Review
Maverick Capital increased its Belite Bio (BLTE) stake by 54% in Q3 2026, buying an estimated $34.7M and bringing the position to 609,906 shares worth $104M. The position accounts for 0.81% of the portfolio, ranked #36.
Maverick Capital first reported a position in BLTE in Q2 2026 and has held it in 2 quarters since. 96 funds tracked by Wall St. Rank hold BLTE as of Q3 2026.
- Maverick Capital held 609,906 shares of Belite Bio worth $104M as of Q3 2026.
- Maverick Capital bought 213,595 Belite Bio shares in Q3 2026, an estimated $34.7M.
- Belite Bio made up 0.81% of Maverick Capital's portfolio in Q3 2026, its #36 holding.
- Maverick Capital first reported a position in Belite Bio in Q2 2026 and has held it in 2 quarters since.
- 96 funds tracked by Wall St. Rank held Belite Bio as of Q3 2026.
Based on Maverick Capital's 13F filing for Q3 2026, filed 16 Nov 2026.